The Bioeconomics of Covid-19
By Judith Levine,
n+1
| 11. 13. 2020
How, exactly, do we value a human life?
Back of the 50 centime emergency note issued in 1916 by the Merksplas Local Board of the National Assistance and Food Committee © Museum of the National Bank of Belgium
Biopower and necropolitics
IN DISCIPLINE & PUNISH Michel Foucault describes the measures taken, as per magisterial edict, in a plague-ridden French city sometime in the late seventeenth century. On the first day of quarantine, everyone is ordered to stay indoors; the doors are locked from the outside. Sentinels are posted at the city gates. Armed guards patrol the town hall.
Each street is placed under the surveillance of a syndic, who visits every house every day, speaking through a window. “Everything that may be observed during the course of the visits—deaths, illnesses, complaints, irregularities—is noted down and transmitted” to the city authorities. A resident who goes out without permission or a syndic who leaves the street may be sent to the gallows. Public health and social control go hand in hand.
The authorities recognize an obligation to the people inside the houses, who receive a kind of care, albeit compulsory: interrogations...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...